BioSpace News Archive

Press Releases

BOTOX® Cosmetic (onabotulinumtoxinA) Receives FDA Approval for Moderate to Severe Vertical Bands Connecting the Jaw and Neck (Platysma Bands)

October 21, 2024
·
13 min read
Press Releases

Nurix Therapeutics Presents Positive Results from the Ongoing Clinical Trial of Its BTK Degrader NX-5948 in Patients with Relapsed/Refractory Waldenstrom’s Macroglobulinemia

October 21, 2024
·
8 min read
Press Releases

Gilead and Merck Announce Phase 2 Data Showing a Treatment Switch to an Investigational Oral Once-Weekly Combination Regimen of Islatravir and Lenacapavir Maintained Viral Suppression in Adults at Week 48

October 21, 2024
·
17 min read
Press Releases

ASDS 2024: New Phase III READY-4 Data Demonstrate Long-Term Safety and Efficacy of Galderma’s RelabotulinumtoxinA (Relfydess™)

October 21, 2024
·
9 min read
Press Releases

AAVantgarde appoints Ms. Lauren Kaskiel as Chief Business Officer

October 21, 2024
·
3 min read
Press Releases

Seaport Therapeutics Closes $225 Million Oversubscribed Series B Financing Round

October 21, 2024
·
5 min read
News

Novartis receives positive CHMP opinion for Kisqali® to help reduce risk of recurrence in people with HR+/HER2- early breast cancer

October 21, 2024
·
21 min read
Press Releases

CVRx announces new CPT® Category I codes for Barostim

October 21, 2024
·
3 min read
Press Releases

Capricor Therapeutics Announces Closing of Underwritten Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

October 21, 2024
·
5 min read
Press Releases

FDA Roundup: October 18, 2024

October 21, 2024
·
7 min read